Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma

Published:1999 Issue:3 Volume:7 Page:186-191
ISSN:1065-7541
Container-title:Radiation Oncology Investigations
language:en
Short-container-title:Radiat. Oncol. Investig.

Author:

Aref Amr,Narayan Samir,Tekyi-Mensah Samuel,Varterasian Mary,Dan Maria,Eilender David,Karanes Chatchada,Al-Katib Ayad

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging,Oncology,Radiological and Ultrasound Technology,Radiation

Reference20 articles.

1. The role of radiation therapy in the management of the non-Hodgkin's lymphomas

2. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone

3. The role of radiation therapy in the treatment of early stage large cell lymphoma

4. Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer

5. Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma;Practical Radiation Oncology;2024-09

2. Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?;Advances in Radiation Oncology;2022-11

3. Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Induction or Consolidation Chemotherapy?;Journal of Clinical Oncology;2022-08-10

4. Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective Review;Practical Radiation Oncology;2021-03

5. Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration;International Journal of Radiation Oncology*Biology*Physics;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3